COVID-19 in Pregnancy
Find comprehensive information on COVID-19 in pregnancy, including Coronavirus in Pregnancy and SARS-CoV-2 Infection in Pregnancy. This resource offers guidance on diagnosis, documentation, and medical coding for healthcare professionals. Learn about managing COVID-19 during pregnancy, clinical considerations, and relevant ICD-10 codes for accurate reporting and billing. Explore the latest research and best practices for treating pregnant patients with coronavirus.
Infection with the SARS-CoV-2 virus during pregnancy.
Fever, cough, shortness of breath, loss of taste or smell, fatigue. May be asymptomatic.
Prenatal clinics, hospitals, obstetrics departments, telehealth consultations.
ICD-10 Code Families
Complete code families applicable to O98.519
When to use each related code
| Description | When to use |
|---|---|
| COVID-19 infection during pregnancy. | Confirmed SARS-CoV-2 infection in pregnant individuals. Use O98.5- for trimester specificity. |
| Influenza infection during pregnancy. | Confirmed influenza virus infection in pregnant individuals. Use O98.5- for trimester specificity. |
| General viral infection in pregnancy, unspecified. | Viral infection complicating pregnancy when a more specific code is not available. Use O98.5- for trimester specificity. |
Best-practice checklist
- ✓COVID-19 pregnancy trimester documented
- ✓Onset date of COVID-19 symptoms
- ✓COVID-19 severity: mild, moderate, severe
- ✓Treatment for COVID-19 in pregnancy
- ✓Fetal monitoring & pregnancy outcomes
Common pitfalls to avoid
Coding COVID-19 in pregnancy requires specifying the trimester. Omitting it impacts reimbursement and data accuracy.
Differentiating COVID-19 symptoms from normal pregnancy changes can lead to inaccurate diagnosis and coding errors.
Clear documentation of pre-existing conditions and COVID-19 related complications is crucial for accurate coding and risk adjustment.
Best-practice tips
- 01Timely PCR testing, coding Z3A.80, ICD-10 O98.5-
- 02Monitor oxygen saturation, code J96.00, J96.01 for respiratory distress
- 03Document pregnancy status with Z33.1, optimize reimbursement with CDI
- 04Isolate, code U07.1, follow ACOG guidelines for compliant care
- 05Vaccinate, code Z23, crucial for maternalfetal health, ICD-10 Z33.1
Step-by-step checklist
- 1
Verify COVID-19 ICD-10 code (O98.5-) and pregnancy status Z34.xx documented.
- 2
Confirm SARS-CoV-2 lab test type and result in chart. Document LOINC code.
- 3
Assess symptoms onset date and gestational age at diagnosis. Review Z3A.xx codes.
- 4
Check for documented risk factors and comorbidities impacting pregnancy.
- 5
Monitor maternal and fetal outcomes. Document complications with SNOMED CT codes.
Ready-to-paste narrative
Patient presents with suspected COVID-19 infection during pregnancy. Presenting symptoms include [Specify symptoms e.g., cough, shortness of breath, fever, loss of taste or smell, fatigue, body aches, sore throat, congestion, nausea, vomiting, diarrhea]. Onset of symptoms was [Date of onset]. Patient is currently in her [Trimester] trimester at [Gestational age] weeks. Vital signs include temperature of [Temperature], heart rate of [Heart rate], respiratory rate of [Respiratory rate], and oxygen saturation of [Oxygen saturation] on room air. Differential diagnosis includes influenza, other respiratory viral infections, and common cold. A SARS-CoV-2 PCR test was ordered to confirm the diagnosis of Coronavirus in Pregnancy. Assessment includes evaluation of maternal and fetal well-being, considering potential complications such as preterm labor, preeclampsia, and fetal growth restriction. Treatment plan includes supportive care, monitoring for disease progression, and consideration of antiviral therapy if clinically indicated. Patient education provided regarding COVID-19 in pregnancy, including isolation precautions, symptom management, and potential risks to maternal and fetal health. Follow-up scheduled for [Date of follow-up] to reassess symptoms and monitor pregnancy progression. ICD-10 code U07.1 (COVID-19) and appropriate pregnancy-related codes will be used for billing and coding purposes. Patient advised to contact the clinic if symptoms worsen or new symptoms develop.
Common questions and answers
What are the evidence-based recommendations for managing COVID-19 in pregnant patients with severe pneumonia?+
Managing severe COVID-19 pneumonia in pregnant patients requires a multidisciplinary approach focusing on maternal and fetal well-being. Current evidence-based recommendations emphasize respiratory support, including supplemental oxygen, high-flow nasal cannula, and mechanical ventilation if necessary, while carefully considering the physiological changes of pregnancy. Corticosteroids like dexamethasone are recommended for pregnant patients with severe COVID-19. Furthermore, clinicians should closely monitor for thromboembolic complications and administer prophylactic anticoagulation as appropriate. Prompt consultation with maternal-fetal medicine specialists, pulmonologists, and infectious disease specialists is crucial. Explore how our comprehensive COVID-19 in pregnancy resource hub provides detailed guidance on managing complex cases.
How does COVID-19 infection during pregnancy impact the risk of preterm birth and other adverse pregnancy outcomes?+
Studies indicate that pregnant individuals infected with COVID-19, especially those with severe disease, are at an increased risk of preterm birth, preeclampsia, and other adverse pregnancy outcomes including stillbirth and cesarean delivery. The risk appears to be higher with severe COVID-19 illness and in later trimesters. Additionally, emerging research suggests a potential association between maternal COVID-19 infection and certain neonatal complications. Consider implementing routine screening for COVID-19 in pregnant patients and prioritizing vaccination to mitigate these risks. Learn more about the latest research on COVID-19's impact on pregnancy outcomes in our dedicated research digest.
What are the current CDC guidelines regarding COVID-19 vaccination in pregnant and breastfeeding women? How do mRNA vaccines affect pregnancy and lactation?+
The CDC strongly recommends COVID-19 vaccination for all pregnant and recently pregnant individuals, as well as those who are breastfeeding or planning to become pregnant. Extensive data demonstrate the safety and effectiveness of mRNA COVID-19 vaccines in these populations. Studies show that vaccination during pregnancy generates antibodies that are transferred to the fetus, offering potential protection against neonatal COVID-19. Furthermore, mRNA vaccines are not thought to pose a risk to lactating individuals or their infants. Clinicians should address patient concerns and emphasize the benefits of vaccination during pregnancy and breastfeeding. Explore our in-depth FAQ section addressing common patient misconceptions about COVID-19 vaccines during pregnancy and lactation.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.